Status: Recruiting
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
This is a prospective randomized controlled trial where quality of life and the effectiveness of treatment will be evaluated in 80 patients with confirmed unilateral primary aldosteronism ,randomly assigned to be either treated surgically with unilateral adrenalectomy or to receive medical treatment with eplerenone.
Participants needed: 80
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Göteborg UniversityUpdated: Apr 6, 2025Locations: 3
Eligibility criteria
Patients with confirmed unilateral PA [+4]
Unwilling or unable to undergo surgery [+3]